Company Services
Make your science, clinical progress, and business strategy understandable to professional readers.
Drugnews is a reader-first biotech business-analysis media platform. We also work with public companies, biotech startups, pharma companies, CDMOs, and medical-technology teams to turn R&D progress, clinical evidence, licensing logic, and capital-market stories into clear company narratives.
Client Experience
Past collaborators
How we help
All collaboration content is built on public information, company-approved disclosure, and professional research frameworks.
Company research and feature articles
We turn pipelines, platforms, clinical positioning, competitive landscapes, and business models into long-form analysis that supports reader judgment.
IR and capital-market narratives
We translate clinical, CMC, regulatory, commercialization, and peer-comparison information into value logic investors can follow.
Social content and distribution
We adapt long-form analysis into readable social summaries, visual posts, and key-message cards that lead back to clear business judgment.
Events and interviews
We design interviews, online briefings, event recaps, and follow-up articles that help professional readers understand a company's market position.